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Abstract
Background: Echocardiographic myocardial performance parameters such as strain and strain rate are increasingly
used to assess systolic and diastolic function in patients with diabetes mellitus and several other clinical and scientific
scenarios. While long-term metabolic marks such as HbA1C are inherently assessed in diabetic patients, the actual
blood glucose level at the very moment of the echocardiographic study has not yet been taken into account for
the assessment of cardiac mechanics. The aim of this study was to investigate the influence of real-time blood
glucose levels on left ventricular (LV) myocardial strain and strain rate in pediatric patients with type 1 diabetes
mellitus (T1DM).
Methods: We performed speckle tracking echocardiography on 39 normotensive pediatric patients with
uncomplicated type 1 diabetes mellitus (mean age 11.5 ± 3.5 years, 40 % female) and 44 sex- and age-matched
healthy controls (mean age 11.4 ± 2.9 years, 45 % female). T1DM patients were sub-categorized according to
their blood sugar levels (with a cutoff of 150 mg/dL) at the moment of the echocardiographic exam. Investigators were
blinded to the participants’ study group status.
Results: Interestingly, diabetic patients with higher blood sugar levels demonstrated significantly increased LV
circumferential strain (p = 0.003) and strain rate (p = 0.005) as well as global longitudinal strain rate (p = 0.002) in
comparison to T1DM patients with lower blood sugar levels or healthy controls.
Conclusions: For the investigation of myocardial performance with sensitive methods such as speckle tracking
echocardiography in diabetic study populations real-time blood sugar levels should be taken into account. Further
studies are needed to verify these findings in large-scale patient cohorts and serial intra-individual measurements
in different metabolic states.
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Background
Quantitative echocardiographic assessment of regional
and global myocardial deformation –strain and strain
rate - is increasingly used for the evaluation of systolic
and diastolic function in diabetic cardiomyopathy and in a
variety of other scientific and clinical scenarios [1–3]. In
health and disease, left ventricular (LV) cardiac me-
chanics are complex and heterogeneously variable in
nature. Hence, sensitive LV performance measurements
in diabetes associated cardiac disease are susceptible to
alterations due to advanced age, disease duration (Kai
O. Hensel, Franziska Grimmer, Markus Roskopf,
Andreas C. Jenke, Stefan Wirth, and Andreas Heusch,
“Subclinical Alterations of Cardiac Mechanics Present
Early in the Course of Pediatric Type 1 Diabetes Melli-
tus: A Prospective Blinded Speckle Tracking Stress
Echocardiography Study,” Journal of Diabetes Research,
Article ID 2583747, in press), diabetic complications
[4], overweight [5], inotropically active drugs [6], etc..
However, there is a total lack of studies on the effect of
short-term alterations in serum glucose levels in
pediatric patients with diabetes mellitus. Children and ad-
olescents with uncomplicated diabetes may serve as an
ideal model to study the effect of blood glucose levels on
myocardial function in the absence of potentially con-
founding factors such as ischemia or renal disease. Varia-
tions in serum glucose are known to significantly affect
myocardial contractility through several molecular mecha-
nisms [7, 8]. For logistical reasons blood sample collection
and echocardiographic examinations oftentimes are per-
formed separately in clinical studies, sometimes with days
or even weeks in between. Alterations in the concentra-
tion of intravenous lipids have been shown to have an im-
mediate effect on myocardial contractility [9]. However,
serum glucose levels at the very moment of the echocar-
diographic assessment have not yet been taken into ac-
count when analyzing myocardial mechanics in diabetic
patients. The aim of this study was to investigate the influ-
ence of real-time blood glucose on the echocardiographic
LV performance parameters strain and strain rate in
pediatric patients with uncomplicated type 1 diabetes
mellitus.
Methods
In order to study the effect of real-time blood sugar levels
on LV myocardial deformation we utilized speckle track-
ing echocardiography to measure LV myocardial strain
and strain rate as previously described [10]. We included
83 children and adolescents; 39 consecutive asymptom-
atic, normotensive children and adolescents (40 % female)
with uncomplicated type 1 diabetes mellitus (T1DM) and
44 age- and sex-matched healthy controls (45 % female).
Exclusion criteria were any signs of diabetes associated
end-organ damage (e.g. proteinuria) as well as other med-
ical conditions that may affect the cardiovascular system.
None of the included patients or volunteers were on
any medication with influence to the cardiovascular
system (other than insulin for the study group). Echo-
cardiographic examinations were performed in a left
lateral decubitus position according to a standardized
protocol using the commercially available ultrasound
device iE33 by Phillips Ultrasound Inc., USA, with a S5-1
Sector Array transducer (Sector 1-5 MHz). A complete
standard 2D study including a spectral and color flow
Doppler examination was carried out according to inter-
national echocardiography guidelines [11]. Three consecu-
tive cardiac cycles were recorded as digital loop for
subsequent quantitative analyses on an off-line work
Table 1 Baseline clinical characteristics and hemodynamics of the study population
Type 1 diabetes mellitus Control p-value
Blood glucose level < 150 mg/dl Blood glucose level > 150 mg/dl (n = 44)
(n = 17) (n = 22)
Age (years) 11.5 ± 3.3 11.5 ± 3.0 11.4 ± 2.9 n.s.
Height (cm) 152.2 ± 19.5 152.8 ± 17.5 154.1 ± 16.8 n.s.
Weight (kg) 44.6 ± 16.2 47 ± 16.2 48.0 ± 16.3 n.s.
Body surface (m2) 1.37 ± 0.3 1.41 ± 0.3 1.4 ± 0.3 n.s.
Body mass index (kg/m2) 18.5 ± 2.3 19.5 ± 3.2 19.6 ± 3.5 n.s.
Exercise routine (1–3) 1.8 ± 0.8 1.7 ± 0.8 2.0 ± 0.7 n.s.
Diabetes duration (years) 3.2 ± 3.8 4.5 ± 3.3 - n.s.
HbA1c (%) 8.3 ± 1.2 8.1 ± 1.2 - n.s.
Heart rate (beats/minute) 81.3 ± 10.8 87.1 ± 11.4 76.2 ± 9.4 0.001
BP systolic (mmHg) 106.3 ± 7.5 104.7 ± 10.9 105.8 ± 9.2 n.s.
BP diastolic (mmHg) 58.2 ± 7.8 58.5 ± 8.2 59.4 ± 9.2 n.s.
Exercise routine level: 1 = in school; 2 = < 3 times/week; 3 = ≥ 3 times/week, p-values calculated with one way ANOVA, post hoc and Mann-Whitney U test, level
of significance = 0.05
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station. XCelera Version 3.1.1.422 by Phillips Ultra-
sound Inc., USA was used for speckle-tracking derived
strain and strain rate measurements. Circumferential
strain and strain rate were assessed in the parasternal
short axis view at the level of the mitral valve and the
papillary muscles. Global longitudinal strain and strain
rate were derived by measuring cardiac deformation in ap-
ical 2-, 3-, and 4-chamber views. A priori the diabetes
group was sub-categorized according to their blood sugar
level at the moment of the echocardiographic examination
in groups with blood glucose levels lower or higher than
150 mg/dL, respectively. For the quantitative deformation
post processing of echocardiographic images the investiga-
tors were blinded to the group status of the participants.
The study was approved by the Witten/Herdecke Univer-
sity Ethics and Clinical Trials Committee and assigned the
trial number 113/2013. Each participant as well as their
legal guardian signed a written informed consent. For eth-
ical reasons it was not feasible to obtain blood chemistry
parameters including serum glucose levels from those
healthy children who voluntarily served as a control group.
Data is presented as mean (± standard deviation) in
tables and in box-whisker-plots with median and inter-
quartile ranges. One way analysis of variance (ANOVA)
and post hoc (Turkey) test as well as Mann-Whitney U
test and post hoc bonferroni correction were used to find
statistically significant differences among the groups. Ac-
cording to post hoc bonferroni correction the statistical
significance level was set to 0.00625 for strain and strain
rate analyses. SPSS Version 22.0 and Microsoft Excel for
Mac 2011 Version 14.4.4 were utilized for statistical ana-
lyses and data presentation.
Table 2 Conventional echocardiographic parameters derived from two-dimensional and Doppler imaging
Type 1 diabetes mellitus Control p-value
Blood glucose level < 150 mg/dl Blood glucose level > 150 mg/dl
(n = 17) (n = 22) (n = 44)
Aortic root (AoR) diameter (cm) 2.28 ± 0.36 2.35 ± 0.33 2.41 ± 0.35 n.s.
Left atrial (LA) diameter (cm) 2.48 ± 0.37 2.58 ± 0.36 2.71 ± 0.45 n.s.
LA/AoR 1.10 ± 0.17 1.11 ± 0.16 1.13 ± 0.16 n.s.
Fractional shortening (%) 33.03 ± 4.48 33.70 ± 3.93 34.78 ± 3.94 n.s.
End-systolic interventricular septal diameter (cm) 0.99 ± 0.21 1.09 ± 0.21 1.17 ± 0.20 0.018
End-diastolic interventricular septal diameter (cm) 0.82 ± 0.16 0.85 ± 0.18 0.89 ± 0.16 n.s.
LV end-systolic diameter (cm) 2.72 ± 0.49 2.66 ± 0.39 2.76 ± 0.41 n.s.
LV end-diastolic diameter (cm) 4.05 ± 0.63 4.01 ± 0.49 4.27 ± 0.46 n.s.
End-systolic LV posterior wall diameter (cm) 1.25 ± 0.18 1.21 ± 0.23 1.27 ± 0.21 n.s.
End-diastolic LV posterior wall diameter (cm) 0.80 ± 0.16 0.78 ± 0.17 0.81 ± 0.15 n.s.
Left ventricular mass (g) 102.49 ± 42.90 100.28 ± 41.01 115.18 ± 37.56 0.02
Relative wall thickness 0.20 ± 0.05 0.19 ± 0.03 0.19 ± 0.03 n.s.
LV end-diastolic volume (ml) 65.84 ± 28.13 72.72 ± 22.11 79.63 ± 27.97 n.s.
LV end-systolic volume (ml) 25.96 ± 9.17 28.98 ± 10.12 31.66 ± 11.78 n.s.
Ejection fraction (%) 61.96 ± 4.20 61.14 ± 5.05 60.16 ± 4.67 n.s.
Stroke volume (ml) 44.0 ± 15.7 45.3 ± 14.1 49.3 ± 18.1 n.s.
Cardiac output (l/min) 3.5 ± 1.2 3.9 ± 1.0 3.7 ± 1.3 n.s.
Mitral inflow: E-Wave (cm/s) 98.77 ± 15.37 93.63 ± 11.19 96.86 ± 14.26 n.s.
Mitral inflow: A-wave (cm/s) 61.30 ± 14.76 60.62 ± 10.53 57.36 ± 10.41 n.s.
E-Wave / A-Wave 1.67 ± 0.32 1.57 ± 0.23 1.72 ± 0.26 n.s.
Mitral deceleration time (s) 0.17 ± 0.04 0.17 ± 0.04 0.18 ± 0.04 n.s.
Isovolumetric relaxation time (s) 0.05 ± 0.01 0.05 ± 0.01 0.05 ± 0.01 n.s.
S’ (cm/s) 7.74 ± 0.88 8.05 ± 1.05 8.17 ± 1.19 n.s.
E’ (cm/s) 12.81 ± 1.94 12.41 ± 1.73 13.03 ± 1.87 n.s.
A’ (cm/s) 5.24 ± 0.92 5.56 ± 1.41 5.51 ± 1.11 n.s.
E’/A’ (cm/s) 2.49 ± 0.47 2.42 ± 0.92 2.48 ± 0.72 n.s.
E/E’ (cm/s) 7.82 ± 1.28 7.65 ± 1.17 7.56 ± 1.42 n.s.
p-values are calculated with one way ANOVA and post hoc test, level of significance = 0.05
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Results
Baseline clinical characteristics and conventional echo-
cardiographic parameters almost invariably did not dif-
fer significantly between the analyzed groups (Tables 1
and 2). Mean age was 11.5 ± 3.5 years in the high blood
sugar diabetes group, 11.5 ± 3.3 years in the low blood
sugar diabetes group and 11.4 ± 2.9 years in the controls.
Mean disease duration (and HbA1c) were 4.5 ± 3.0 years
(8.3 ± 1.2 mg/dL) in T1DM patients with high blood sugar
and 4.5 ± 3.3 years (8.1 ± 1.2 mg/dL) in T1DM patients
with low blood sugar at the moment of the echocardio-
graphic examination. Exceptions are a slightly higher but
normal heart rate in T1DM patients with blood sugar
levels > 150 mg/dL (87.1 ± 11.4 versus 81.3 ± 10.8 bpm)
and a greater end-systolic interventricular septal diam-
eter (1.17 ± 0.20 vs. 1.09 ± 0.21 cm) and LV mass (115.2
± 37.6 vs. 100.3 ± 41 g) in healthy controls. Even though
statistically significant these differences were marginal
and all values were within normal limits as evaluated by
z-scores [12].
The effect of real-time serum glucose levels on myo-
cardial deformation parameters is demonstrated in
Fig. 1. T1DM Patients with blood sugar levels higher
than 150 mg/dL at the time of the echocardiographic
examination had significantly increased (more negative)
peak LV circumferential strain (p = 0.003), circumferen-
tial strain rate (p = 0.005) and longitudinal strain rate
(p = 0.002) values than patients with lower real-time
blood sugar levels or healthy controls (Table 3). The
difference in global longitudinal strain showed the same
tendency with increased values in T1DM patients with
higher real-time blood sugar levels when compared to
T1DM patients with lower blood sugar levels, however
without reaching statistical significance. A speckle-tracking
echocardiography example of increased global LV peak cir-
cumferential strain in a patient with elevated serum glu-
cose is shown in Fig. 2. The results were reproducible and
inter-observer variability was below 6 %.
Discussion
Myocardial performance is influenced by a variety of
non-metabolic and metabolic factors [13]. When study-
ing myocardial function in clinical and scientific scenar-
ios, usually only long-term influences are taken into
account [14]. Currently, there are no studies on the ef-
fect of short-term blood glucose alterations on cardiac
mechanics in pediatric patients with diabetes mellitus.
However, acute metabolic changes have been shown to
substantially alter cardiac function. Holland et al. demon-
strated, that the infusion of an intravenous fat emulsion to
acutely raise plasma triglycerides alters ventricular-vascular
interaction by increasing left ventricular contractility with-
out affecting arterial load [9]. Recently, longitudinal strain
was shown to be influenced by fasting plasma glucose
levels in adult patients with type 2 diabetes mellitus [15].
To our knowledge the present study is the first clinical
study in humans to assess the influence of real-time blood
sugar levels on myocardial performance parameters strain
and strain rate in a diabetic study population.
Interestingly, we found strain and strain rate to be in-
creased (more negative) in diabetic children with ele-
vated real-time blood sugar levels when compared to
T1DM patients with lower blood sugar levels and
healthy controls (Table 3, Fig. 1). This is in line with an
in vitro finding of the acute influence of fructose on
cardiomyocyte excitation-contraction coupling [16] – a
Fig. 1 Myocardial deformation in type 1 diabetes mellitus patients and healthy controls in relation to serum glucose levels at the moment of the
echocardiographic examination. a: LV peak systolic global circumferential strain in healthy controls and T1DM patients. b: LV peak systolic global
longitudinal strain rate in healthy controls and T1DM patients. * = p < 0.00625; p-values were calculated with one way ANOVA and post hoc tests
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molecular mechanism that might explain the results of
the present study. The fact that circumferential strain,
circumferential strain rate and longitudinal strain rate
but not longitudinal strain were significantly higher in
T1DM patients with increased blood sugar levels can well
be explained by the strong heterogeneity of myocardial fiber
organization in the LV and the natural consequence of re-
gional variations in myocardial deformation [17, 18]. Hence,
transient metabolic laboratory biochemistry parameters
such as serum glucose levels may affect LV myocardial
performance. Consequently, blood glucose and lipid
studies should be obtained close to the time of the
echocardiographic examination when assessing cardiac
mechanics with sensitive tools such as speckle-tracking.
Baseline characteristics of the study groups did not
differ significantly between the analyzed groups besides
for a slightly higher heart rate in T1DM patients with
blood sugar levels higher than 150 mg/dL (87.1 ± 11.4
Table 3 Speckle tracking echocardiography derived peak LV circumferential and longitudinal strain and strain rate of T1DM patients
and healthy controls
Type 1 diabetes mellitus Control p-value
Blood glucose level <150 mg/dl Blood glucose level >150 mg/dl
(n = 17) (n = 22) (n = 44)
Circumferential strain -24.24 ± 3.11 -28.81 ± 4.84 -25.95 ± 3.92 0.003
Circumferential strain rate -1.96 ± 0.26 -2.12 ± 0.40 -1.86 ± 0.25 0.005
Global longitudinal strain -19.55 ± 2.27 -20.57 ± 2.41 -20.72 ± 2.49 n.s.
Global longitudinal strain rate -1.51 ± 0.26 -1.85 ± 0.51 -1.55 ± 0.21 0.002
p-values are calculated with one way ANOVA and post hoc test, level of significance = 0.00625
Fig. 2 Speckle tracking echocardiography in the parasternal short axis view at level of the papillary muscles. a peak systolic global LV
circumferential strain in a pediatric patient with type 1 diabetes mellitus and real time serum glucose level < 150 mg/dL. b peak systolic global LV
circumferential strain in a pediatric patient with type 1 diabetes mellitus and real time serum glucose level > 150 mg/dL. Note the increased (more negative)
peak LV systolic global circumferential strain in the diabetic patient with the higher blood sugar level (b)
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versus 81.3 ± 10.8 bpm; Table 1). Even though statistically
significant, this difference in heart rate is unlikely to be a
biologically relevant cause for the above described alter-
ations in myocardial strain and strain rate. Boettler and
colleagues have found differences in heart rate mainly to
affect strain rate in diastole other than in systole [19]. Fur-
thermore, systolic strain has been shown to decrease with
increasing heart rate [20]. This means, that if heart rate
had a significant influence on strain and strain rate in our
study population, it would actually lead to depressed strain
values in T1DM patients with high blood sugar levels.
Hence, the finding of increased strain in combination with
a slightly higher heart rate in T1DM patients with high
blood sugar levels even strengthens the significance of
real-time blood glucose for myocardial performance pa-
rameters as demonstrated in this study. Nevertheless, it
has to be stated that the here reported changes represent
subtle, subclinical alterations only. As the study partici-
pants do not suffer from overt heart disease but exhibit
uncomplicated T1DM with a relatively short disease dur-
ation (mean 4 ± 3.5 years) only, it is not surprising that the
demonstrated differences in strain and strain rate are
not more pronounced. Outcome-relation and clinical
implications yet have to be determined by further stud-
ies. Hypothetically, hyperglycemia-induced increased
energy turnover may lead to hyperdynamic cardiac me-
chanics in diabetes associated cardiomyopathy which
on the long run might contribute to the development
of diabetic cardiomyopathy. Experimental animal studies
utilizing speckle tracking echocardiography in hypergly-
cemic ketoacidosis and hypoglycemic states should be per-
formed to further illuminate the spatiotemporal course of
diabetes associated cardiac disease.
Study limitations are the fact that this is an observa-
tional study in a limited number of patients. In order
to correlate the findings of altered myocardial strain
and strain rate with a clinical outcome, long-term
follow-up studies in large-scale cohorts are necessary.
These studies should include adult individuals and ser-
ial intra-individual echocardiographic assessments in
states of different blood glucose levels both in diabetic
and healthy control patients, which was not feasible for
this study due to ethical restrictions. These further studies
are needed to ultimately establish the value of real time
glucose level measurements for the evaluation of the myo-
cardial contractile state using sensible methods such as
speckle-tracking echocardiography.
Conclusion
LV myocardial strain and strain rate in pediatric patients
with T1DM may be influenced by short-term alterations in
metabolic parameters like blood sugar levels. Our findings
provide an impetus for future experimental and clinical
studies directed to investigate the mechanism of real-time
blood glucose concentration on cardiac mechanics. Studies
investigating other influential factors on myocardial per-
formance in patients with diabetes should exclude the in-
fluence of short-term alterations in serum blood sugar as a
potential confounder. Blood glucose levels should be mea-
sured close to the timing of the echocardiographic examin-
ation when assessing myocardial mechanics with sensible
tools such as speckle tracking echocardiography.
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